Latest hum. ProductsDetails
Product Name in the RMS: Co-Dalnessa 4 mg/ 1.25 mg/ 5 mg
MR Number: HU/H/0342/002
Date of outcome: 23.10.2013
| Type of application | |
|---|---|
|
Level 1: Level 2: Level 3: Level 4: Level 5: |
Known Active Substance Initial Application Fixed Combination Chemical Substance Prescription Only |
| Active Substances |
amlodipine besilate 5 mg indapamide 1,25 mg perindopril tert-butylamine 4 mg |
| Form | Tablet |
| MA Holder in the RMS | Krka, d.d., Novo mesto |
| RMS | Hungary |
| Date of last change | 20.08.2020 |
| ATC-Code |
C02N COMBINATIONS OF ANTIHYPERTENSIVES IN ATC-GR. C02 |
| CMS Country | Domestic Product Name |
|---|---|
| Bulgaria | Co-Amlessa |
| Czech Republic | Amlecombi 4 mg/ 5 mg/ 1.25 mg tablety |
| Estonia | CO-DALNESSA |
| Latvia | Co-Amlessa 4 mg/5 mg/1,25 mg tabletes |
| Lithuania | Co-Amlessa 4 mg/5 mg/1,25 mg tabletės |
| Poland | Co-Amlessa |
| Romania | Co-Amlessa 4 mg/ 1.25 mg/ 5 mg comprimate |
| Slovak Republic | Co-Amlessa 4 mg/5 mg/1,25 mg tablety |
| Slovenia |
| Documents | |
|---|---|
| PAR: | HU_H_0342_002_PAR.pdf (17.02.2014) |
